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Abstract
Aortic stiffness is associated with an increased risk of cardio- and cerebrovascular disease and mortality and may increase 
risk of dementia. The aim of the present study is to examine the association between arterial stiffness and cognitive decline 
in a large prospective cohort study with three repeated cognitive assessment over 7 years of follow-up. Aortic pulse wave 
velocity (PWV) was measured among 4300 participants (mean ± standard deviation age 65.1 ± 5.2 years) in 2007–2009 and 
categorized based on the tertiles: (lowest third: < 7.41 m/s), (middle third: 7.41–8.91 m/s), and (highest third: > 8.91 m/s). 
A global cognitive score was calculated in 2007–2009, 2012–2013, and 2015–2016 based on responses to memory, reason-
ing and fluency tests. Standardized global cognitive score (mean = 0, SD = 1) in highest third versus lowest third of PWV 
category was lower at baseline (− 0.12, 95% CI − 0.18, − 0.06). Accelerated 7-year cognitive decline was observed among 
individuals with the highest PWV [difference in 7-year cognitive change for highest third versus lowest third PWV: − 0.06, 
95% CI − 0.11, − 0.01, P < 0.01]. Higher aortic stiffness was associated with faster cognitive decline. Clinicians may be able 
to use arterial stiffness severity as an indicator to administer prompt treatments to prevent or delay the onset of cognitive 
decline or dementia. Future studies need to determine whether early intervention of vascular stiffness is effective in delaying 
these outcomes.
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Introduction
The substantial expansion in life expectancy and popula-
tion ageing is a major achievement but also one of the 21st 
century public health challenges. Ageing is associated with 
exponential increases in number of people living with cogni-
tive impairment and dementia, both of which reduce quality 
of life [1, 2]. The number of people with dementia is pro-
jected to increase from 0.7 M in 2016 to 1.2 M by 2040 in 
England and Wales [3].
Aortic stiffness, due to loss of elasticity of the artery wall, 
increases with age and risk factor exposure [4–7] is associ-
ated with higher systolic, pulse pressure and atherosclerosis 
[8], which are in turn important predictors of cardio- and 
cerebrovascular morbidity and mortality as well as predic-
tors of cognitive decline [9]. The links between cardiovas-
cular disorders and cognitive decline and dementia remain 
unclear. If such vascular pathophysiological alterations are 
better understood, it may be possible to prevent or delay 
cognitive decline and improve quality of life in older people.
Aortic pulse wave velocity (PWV) is the non-invasive 
gold standard to determine arterial stiffness [10]. Small-
scale observational studies (eight cross-sectional studies 
and five prospective cohort studies) [11–23] have assessed 
the association of arterial stiffness with cognitive impair-
ment, but their results are inconsistent. It was suggested that 
arterial stiffness may influence specific cognitive domains 
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such as executive function [11, 20], memory [18, 19, 22], 
and processing speed [11]. Longitudinal cognitive test data 
spanning a decade were rare, with small sample size and 
may have biases attributable to selective attrition (leading 
to younger persons with better cognitive function over-rep-
resented at follow-up). This limits interpretation of previ-
ous studies. Further, cognitive function was mainly assessed 
with the Mini-Mental State Examination (MMSE), a global 
test with low sensitivity for detection of small changes in 
cognitive status [24].
Our study is the first longitudinal study with a sensitive 
cognitive measure (cognitive test battery), large sample size, 
and high response rate for all three measures of cognitive 
function (Phases 9, 11, and 12) to examine whether arterial 
stiffness is associated with deficits and changes in specific 
cognitive domains. In addition, risk of attrition bias was con-
trolled for using inverse probability weighting to account for 
missing data over the follow-up period. We hypothesized 
that higher PWV would be associated with both concur-
rently assessed cognitive performance and subsequent cog-
nitive decline. We examined a global measure of cognitive 
function, and the cognitive domains of memory, executive 
function and verbal fluency using data on 4300 individuals.
Methods
Study population
The Whitehall II study is a longitudinal cohort study, ini-
tially of 10,308 (67% men, aged 35–55 years) London-based 
British civil servants, recruited in 1985. Since then, follow-
up questionnaire surveys and clinical examinations have 
taken place every 2–3 years and 5 years, respectively. Ethical 
approval for each study phase was obtained from the NHS 
National Research Ethics Service and the local Research 
Ethics Committee. All participants provided written consent 
prior to each study phase.
The 2007–2009 clinical examination was attended by 
6225 participants. Of these, 4300 participants provided data 
on both PWV and cognitive function, forming the analytic 
sample to examine the association between PWV and cog-
nitive trajectories (Fig. 1). The association between PWV 
and “pronounced cognitive decline” was assessed in analysis 
based on 3828 participants.
Aortic PWV
PWV was assessed between the carotid and femoral sites 
using applanation tonometry (SphygmoCor, Atcor Medi-
cal, Australia), a validated method of measuring PWV. Path 
length was determined with a tape measure by subtracting 
the carotid-sternal notch distance from the femoral-sternal 
notch distance. PWV was measured twice for each partici-
pants and a third measurement was taken when the difference 
between the two measurements were larger than 0.5 m/s. 
The average of all the measurements was used in the analy-
sis. PWV measurements were repeated within 60 days for 
125 participants to assess short-term repeatability. Median 
difference of the repeats were 0.83 m/s (interquartile range 
0.43–1.40).
Cognitive function
The cognitive test battery was administered at the clinical 
examinations in 2007–2009, 2012–2013, and 2015–2016. 
Test–retest reliability was assessed in 556 participants 
within 3 months and showed excellent reliability (range 
0.6–0.9). The cognitive tests were as follows. Memory: 
participants were presented with a 20-word list of one or 
two syllable words at two second intervals, with 2 min time 
to write down as many words as they can recall, regard-
less of word order. Reasoning: participants had 10 min to 
complete the AH4-I (Alice Heim 4-I), a series of 65 verbal 
and mathematical reasoning items of increasing difficulty. 
Verbal Fluency: phonemic fluency was assessed via the “S” 
words and semantic fluency via “animal” words tests. One 
minute was allowed for each test. To reduce measurement 
error and ease comparison between tests with different score 
ranges, we standardized all raw test scores for these four 
measures to z-scores (mean = 0, standard deviation [SD] = 1) 
and summed and re-standardized the scores to yield a global 
cognitive score, as in previous studies [25, 26]. The 30-item 
Mini-Mental-State-Examination (MMSE) was also used in 
supplementary analyses, as an alternative measure, to assess 
global cognitive status.
Baseline characteristics
Sociodemographic variables included age, sex, ethnicity 
(white, others), socioeconomic status using employment 
grade (three categories: high, intermediate, and low rep-
resenting income and status at work), and education (five 
categories: less than primary school (up to age 11), lower 
secondary school (up to age 16), higher secondary school 
(up to age 18), university, and higher university degree).
Health behaviors were assessed by questionnaire and 
included smoking (current smokers, ex-smokers, and never 
smokers) and, alcohol consumption (number of alcoholic 
drinks consumed in the previous days, converted to units of 
alcohol consumed in a week and categorized as “no/occa-
sional alcohol consumption,” “moderate alcohol consump-
tion” (1–14 units/week), and “heavy alcohol consumption” 
(≥ 14 units/week)).
Health related covariates included body mass index 
assessed at the clinical examination (categorized as < 20, 
863Association of aortic stiffness with cognitive decline: Whitehall II longitudinal cohort…
1 3
954 died prior to Phase 9
2,593 were drop-outs / non-responder at Phase 9 
For 469, cognitive change was not calculated:
No cognitive function data at baseline (Phase 9), N = 49
Cognitive function measured only at baseline, N = 420
1,878 did not have PWV measures 
Study 3,831 participants at baseline (Phase 9) with known 
PWV and cognitive change over time 
4,347 participants with PWV measured
2007-2009
6,761 participated at Phase 9 (clinic or questionnaire)
2007-2009
6,225 participated at Phase 9 clinic
536 completed Phase 9 questionnaire only, but did not 
attend clinic
4,300 participants with PWV and ≥1 measure of cognitive 
function at Phases 9, 11 or 12 
47 had no cognitive measures at any of 
Phases 9, 11 or 12 
3,828 in study sample for sensitivity analysis of association 
between PWV and accelerated cognitive decline
3 had missing covariates at baseline (Phase 9)
10,308 in full Whitehall II cohort
(Phase 1) 1985-1988
Fig. 1  Study flowchart
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20–24.9, 25–29.9, and ≥ 30 kg/m2), hypertension (systolic/
diastolic blood pressure ≥ 140/90 mm Hg or use of antihy-
pertensive drugs), self-reported use of drugs, prevalent dia-
betes mellitus (determined by fasting glucose ≥ 7.0 mmol/L, 
reported diabetes diagnosed by a doctor, or use of diabetes 
drugs), and cardiovascular diseases (CVD) (including coro-
nary heart disease and stroke (identified using linkage to 
national hospital records)).
Statistical analysis
Linear mixed models were used to estimate both the cross-
sectional and the longitudinal association of PWV with the 
global cognitive score. These methods use all available cog-
nitive data over the three measures and take into account 
the fact that repeated measures on the same individual are 
correlated with each other. The intercept and the slope were 
fitted as random effects, allowing individuals to have differ-
ent cognitive scores at baseline and different rates of cogni-
tive decline over the follow-up. The PWV distribution was 
categorized into thirds: (lowest third: < 7.41 m/s), (middle 
third: 7.41–8.91 m/s), and (highest third: > 8.91 m/s).
We then fitted the mixed models using these categories 
of PWV with global cognitive score and also for each cog-
nitive domain as the dependent variable. Since the mean 
follow-up (time between the first and last cognitive measure) 
was 7.3 years, we expressed the changes in the cognitive 
measures per 7 years. The PWV × time × sex interactions 
suggested no sex differences in the PWV associations with 
cognitive function or with cognitive decline (all P > 0.14) 
and, therefore, all analyses were conducted with men and 
women combined. All analyses were adjusted for sex, age, 
ethnicity and employment grade by fitting these terms and 
their interactions with follow-up time. Please see the supple-
mentary materials (Model specification) for the full model 
specification. We also used MMSE < 27 and MMSE < 26 as 
two ways to define those with cognitive decline and fitted 
mixed logistic models with these two outcomes, adjusting 
for age, sex, ethnicity and employment grade, as above. We 
conducted a sensitivity analysis to assess the potential bias 
caused by selective attrition over the follow-up period by 
refitting the models using generalized estimating equations 
and using inverse probability weights for each observation 
[27]. The inverse probability weights were obtained by using 
the 6225 individuals who participated at the Phase 9 clinic 
and fitting three logistic models to predict which individuals 
were included in the analysis at Phases 9, 11 and 12 respec-
tively. These logistic models used covariates ascertained 
at Phase 9 where possible and included sociodemographic 
factors (age, sex, ethnicity, marital status and employment 
grade), behavioral factors (smoking status, alcohol consump-
tion and level of physical activity), chronic conditions (cor-
onary heart disease, stroke and diabetes), cardiometabolic 
risk factors (body mass index, systolic and diastolic blood 
pressure and serum cholesterol), mental health (General 
Health Questionnaire caseness) and medication use (anti-
hypertensive and lipid lowering).
In order to assess the robustness of the association 
between PWV and cognition, we examined whether PWV 
was a predictor of which individuals had the most pro-
nounced cognitive decline. A linear mixed model was first 
used to estimate the decline in global cognitive score across 
the three waves of data collection for each participant. A 
binary outcome variable was then created to indicate the 
20% of participants with the fastest cognitive declines com-
pared to those of similar age, sex and employment grade. 
This was achieved by creating twenty-four 5-year age group 
by sex by employment grade strata and selecting the 20% of 
participants with the fastest cognitive declines within each of 
these strata. Logistic regression models were fitted and odds 
ratios (ORs) and corresponding 95% confidence intervals 
(95% CIs) calculated to estimate the association between 
PWV and the fastest rate of cognitive decline. These models 
were adjusted for sex, age, ethnicity and employment grade 
to ensure that there was no residual confounding from these 
covariates. A sensitivity analysis was conducted to assess 
the robustness of the estimates to using a different range 
of thresholds (10–25%) for the proportion of participants 
with the fastest cognitive decline. Statistical significance was 
inferred as a two-tailed P value < 0.05.
The figure showing the global cognitive score trajecto-
ries with time was produced using StataSE 15.1. All other 
models were fitted using the Proc Mixed, Proc Glimmix and 
Proc Genmod procedures from the SAS software version 9.4 
(SAS Institute, Cary, NC, USA).
Results
Figure 1 shows the number eligible participants included in 
the analysis. Of the 10,308 participants at study inception 
(1985–1988), 954 had died, 2593 had withdrawn from the 
study, and 536 did not attend clinic in 2007–2009. Our first 
analysis was based on 4300 of the 6225 individuals still in 
the study. Those included in the analyses were more edu-
cated (40% vs. 32% had a university degree, P < 0.001), were 
younger (65 years vs. 67 years, P < 0.001) and generally had 
a healthier risk factor profile than those excluded (Supple-
mentary Table 1). Demographic and clinical characteristics 
at baseline among those included in the analyses are shown 
in Table 1 according to the thirds of PWV. Participants in the 
highest third were older and had a more adverse risk factor 
profile than those in the lowest third.
Cross-sectional and longitudinal associations between 
PWV and global cognitive score and individual cogni-
tive domains, are shown in Table 2. In the cross-sectional 
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analysis, global cognitive score was significantly lower in 
the middle third and the highest third of PWV (> 8.91 & 
7.41–8.91 m/s) compared to the lowest third (< 7.41 m/s). 
A cross-sectional association was seen for the highest third 
with all cognitive domains (P < 0.05), compared to the 
lowest third. In the longitudinal analysis, global cognitive 
function declined significantly faster in the highest third 
compared to the lowest third after adjustment for age, sex, 
ethnicity and employment grade [difference in 7-year change 
in score for > 8.91 m/s versus < 7.41 m/s = − 0.06 (− 0.11 to 
− 0.01), P = 0.01]. Similar effects were seen for some of the 
cognitive domains but only with phonemic fluency the asso-
ciation was statistically significant (P = 0.03). The estimates 
changed little when the analyses were repeated using inverse 
probability weights to allow for potential selection bias with 
the cross-sectional effects being slightly strengthened and 
the longitudinal effects marginally weakened (Supplemen-
tary Table 2). The cross-sectional estimate of the highest 
Table 1  Baseline characteristics of 4300 participants in the study sample according to the thirds of pulse wave velocity
[Mean (SD) or %] P value for 
heterogeneity
Thirds of baseline pulse wave velocity (m/s)
Lowest third (< 7.41) Middle third 
(7.41–8.91)
Highest third (> 8.91)
Number 1436 1438 1426
Age (y) 63.1 (4.9) 64.8 (5.5) 68.0 (5.6) < 0.001
Female (%) 28.9 25.1 21.7 < 0.001
Non-white ethnicity (%) 5.6 6.9 10.4 < 0.001
Body mass index (kg/m2) < 0.001
 Underweight (< 18.5) 1.1 0.6 0.9
 Normal weight (18.5–24.9) 50.1 37.1 32.7
 Overweight (25.0–29.9) 37.7 47.3 48.2
 Obese (≥ 30.0) 10.4 15.0 18.2
Systolic blood pressure (mm Hg) 117.6 (13.4) 124.0 (13.9) 132.0 (15.5) < 0.001
Diastolic blood pressure (mm Hg) 67.5 (9.4) 71.0 (9.5) 73.5 (10.3) < 0.001
Anti-hypertension medication (%) 23.6 32.9 41.6 < 0.001
Serum cholesterol (mmol/L) 5.28 (1.03) 5.19 (1.04) 5.17 (1.09) 0.009
Lipid lowering medication (%) 23.3 32.0 36.6 < 0.001
Education < 0.001
 ≤ Lower secondary 26.4 32.7 36.9
 Higher secondary 29.5 28.1 26.6
 ≥ Degree 44.1 39.2 36.5
Employment grade 0.04
 High 51.9 49.3 48.2
 Intermediate 40.7 42.5 41.5
 Low 7.4 8.2 10.3
Smoking habit 0.03
 Never 51.4 47.3 48.6
 Ex-smoker 43.4 47.0 47.5
 Current 5.2 5.8 3.9
Alcohol consumption < 0.001
 No alcohol 14.5 17.1 17.6
 Moderate alcohol 71.7 65.3 64.2
 Heavy alcohol 13.8 17.6 18.1
Moderate or vigorous physical activity 0.01
 < 1 h/wk 19.3 23.4 23.2
 1–6.9 h/wk 61.7 59.7 61.3
 ≥ 7 h/wk 19.0 17.0 15.5
Diabetes (%) 5.9 9.5 18.5 < 0.001
History of cardiovascular disease (%) 9.6 10.8 14.7 < 0.001
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third of PWV increased by less than 1% when the 5 prevalent 
dementia cases were excluded and the longitudinal effect of 
the highest third of PWV on cognitive function was reduced 
by 5% when the 10 incident cases of dementia were excluded 
from the analysis. When participants with a history of CVD 
were excluded from the analyses, the cross-sectional esti-
mate of the highest third of PWV was reduced by 11% but 
remained statistically significant (P = 0.002), and the longi-
tudinal effect was reduced by 4% and remained statistically 
significant (P = 0.03). When we adjusted for cholesterol 
levels, the cross-sectional estimate of the highest (vs. low-
est) third of PWV decreased by 11% and the longitudinal 
estimate decreased by 2%.
The declines in global cognitive score with time, after 
adjustment for sex, ethnicity and employment grade, are 
shown for the three PWV categories in Fig. 2. The global 
cognitive scores decrease fastest for those in the highest third 
of PWV such that the difference between the highest and 
lowest third of PWV after 7 years is 50% greater than at 
baseline (− 0.18 vs. − 0.12). We assessed the association 
between MMSE and PWV, both cross-sectionally and longi-
tudinally and the results were not significant (Supplementary 
Table 3).
In the analyses to predict those with the fastest cogni-
tive declines as the outcome (binary variable of top 20% 
vs. rest), individuals in the highest third of PWV were 40% 
more likely to exhibit rapid declines in cognitive function 
during prospective follow-up (OR 1.40, 95% CI: 1.13, 1.73), 
following adjustment for age, sex, ethnicity and employment 
grade (Table 3). Excluding 4 participants who had prevalent 
Table 2  Cross-sectional 
and longitudinal association 
between the thirds of pulse wave 
velocity and standardized scores 
of global cognitive score and 
individual cognitive domains
a Differences are adjusted for age and sex and their interactions with time and time squared and for ethnicity 




Pulse wave velocity Standardized cognitive score at 
baseline
Change in standardized cogni-
tive score (per 7 years)
Differencea (95% CI) P value Differencea (95% CI) P value
Global cognitive score
Lowest third 1.0 (Ref) – 1.0 (Ref) –
Middle third − 0.06 (− 0.12, − 0.01) 0.03 − 0.02 (− 0.06, 0.03) 0.48
Highest third − 0.12 (− 0.18, − 0.06) < 0.001 − 0.06 (− 0.11, − 0.01) 0.01
Memory
Lowest third 1.0 (Ref) – 1.0 (Ref) –
Middle third − 0.04 (− 0.10, 0.03) 0.28 0.04 (− 0.03, 0.11) 0.23
Highest third − 0.12 (− 0.19, − 0.05) < 0.001 − 0.01 (− 0.08, 0.07) 0.84
AH4-I
Lowest third 1.0 (Ref) – 1.0 (Ref) –
Middle third − 0.06 (− 0.12, 0.00) 0.03 0.01 (− 0.02, 0.05) 0.52
Highest third − 0.08 (− 0.13, − 0.02) 0.01 − 0.03 (− 0.07, 0.01) 0.09
Phonemic fluency
Lowest third 1.0 (Ref) – 1.0 (Ref) –
Middle third − 0.08 (− 0.15, − 0.01) 0.02 − 0.03 (− 0.09, 0.04) 0.45
Highest third − 0.10 (− 0.17, − 0.03) 0.007 − 0.08 (− 0.15, − 0.01) 0.03
Semantic fluency
Lowest third 1.0 (Ref) – 1.0 (Ref) –
Middle third − 0.02 (− 0.09, 0.04) 0.45 − 0.05 (− 0.11, 0.00) 0.06
Highest third − 0.08 (− 0.14, − 0.01) 0.03 − 0.06 (− 0.13, 0.00) 0.06
Fig. 2  Trajectories (The trajectories of global cognitive score are the 
predicted values that come from the mixed model that was used to 
estimate the effects of pulse wave velocity on global cognitive func-
tion shown in Table 2) of global cognitive score with follow-up time 
from baseline examination according to thirds of pulse wave velocity
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dementia and 10 who had dementia diagnosed during the 
follow-up made little impact and the coefficient for PWV 
was reduced by less than 1%. Further sensitivity analyses 
assessing different percentages (10, 15, 20, and 25%) of par-
ticipants with the fastest cognitive declines were broadly 
consistent with the main findings (Supplementary Table 4).
Discussion
Aortic stiffness was associated with faster global cogni-
tive decline over seven years of follow-up. Individuals 
in the highest third of PWV compared to the lowest had 
40% higher odds of cognitive decline. We aimed to iden-
tify whether specific cognitive domains contributed to the 
global decline, but no robust association between arterial 
stiffness and cognitive decline in all cognitive domains were 
observed. Decline in phonemic fluency was most clearly 
associated with aortic stiffness, while decline in reasoning 
capacity assessed by the AH4-I was linked with aortic stiff-
ness only marginally.
Although several studies [11–20] have identified an 
inverse association between aortic stiffness and cognition, 
a few studies [21–23] did not find an association. Our large 
longitudinal study adds to the evidence that aortic stiffness 
predicts cognitive decline. Several proposed pathways link 
aortic stiffness to cognitive decline. First, the stiff aorta loses 
its cushioning capacity and promotes transmission of poten-
tially deleterious central pressure pulses to the fragile small 
vessels of target organs such as the brain. Increased pulsa-
tile flow in the brain may accelerate intracranial stenosis, 
and dysfunction in the cerebral microcirculation [28, 29]. 
Second, chronic cerebral hypoperfusion may induce cer-
ebral white matter injury or lead to toxic metabolic byprod-
ucts accumulation within the brain and blood vessels [30]. 
Moreover, thrombosis and microinfarcts that can be caused 
as a result of thickening of the cerebrovascular endothelium 
and associated endothelial dysfunction are also apparent in 
malignant hypertension [31]. Third, arterial stiffness is asso-
ciated with the risk of developing stroke [32] and it has been 
confirmed that stroke could result in the cognitive impair-
ment [33].
Previously, a study reported concurrent decline in both 
phonemic and sematic fluency in a group of people with 
mild cognitive impairment (MCI) [34], while another study 
[35] showed that individuals with MCI performed worse on 
phonemic fluency than sematic fluency. While the under-
lying mechanisms remained largely unknown, evidence 
shows that multiple brain regions involves during fluency 
tasks, phonemic fluency tasks are proposed to rely mainly 
upon executive functioning and pre-frontal lobe processes, 
whereas sematic fluency tasks are proposed to rely on tem-
poral lobe process [36]. The findings of present study sup-
port the hypothesis that aortic stiffness is linked to cognitive 
decline mediated by frontal lobe atrophy as a result of small 
vessel disease.
Our findings were in accordance with those from the 
Health, Aging and Body Composition (Health ABC) study 
(N = 2488) [17], which found associations between higher 
arterial stiffness, as measured by PWV, and more rapid cog-
nitive decline, as measured by MMSE over nine years of 
follow-up. Additionally, previous results from a sub sample 
(N = 552) [18] of older adults in Health ABC found an asso-
ciation between higher PWV and greater cognitive decline 
on the psychomotor speed only but not on tests of memory 
and global cognitive function. Furthermore, findings from 
Baltimore Longitudinal Study of Aging (BLSA) (N = 582) 
[19] showed significant associations between higher PWV 
and more rapid cognitive decline on the Blessed Information 
Memory Concentration Test (working memory test). How-
ever, results from the BLSA study did not provide evidence 
for an association between PWV and tests of global cogni-
tive function [19]. In contrast to our findings, PWV did not 
predict cognitive decline between two time points over an 
average of 5 years in the Rotterdam Study [23].
The inconsistency of results across studies may due 
to differences in aspects of study design, including the 
specific neuropsychological tests used, sample size of 
the study, and differences in participant’s characteristics. 
Many studies used MMSE to assess cognitive impairments 
Table 3  Association between pulse wave velocity and accelerated global cognitive decline during follow-up
a The cut-points for those with the greatest cognitive decline are age, sex and employment grade specific and are based upon the 3828 partici-
pants in this analysis
b Odds ratios of being in the group with the greatest cognitive decline are adjusted for age, sex, ethnicity and employment grade
Pulse wave velocity No. participants The 20%a of participants with the greatest cogni-
tive decline over the follow-up, N (%)
Odds  ratiob (95% CI) P value
Lowest third 1316 224 (17.2%) 1.0 (Ref)
Middle third 1300 265 (20.4%) 1.23 (1.01, 1.51) 0.04
Highest third 1212 281 (23.2%) 1.40 (1.13, 1.73) 0.002
Effect per 1 SD increase 3828 770 (20.1%) 1.11 (1.02, 1.21) 0.02
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in adults. It has been suggested that MMSE is not a suit-
able measure for cognitive function among healthy par-
ticipants due to the ceiling effect. Moreover, MMSE is 
insensitive to small changes in cognitive function [24]. 
The sample size is crucial to provide adequate statistical 
power. Previous studies of the association of arterial stiff-
ness measured by PWV with cognitive decline had fewer 
than 500 participants.
Our study is the first population-based study to exam-
ine the association between arterial stiffness and cognitive 
decline in a large prospective cohort study of British civil 
servants who underwent three repeated cognitive assess-
ment over 7 years of follow-up. The PWV is regarded as 
the gold standard for measuring arterial stiffness and thus 
provides a great strength to our study. We examined the 
influence of arterial stiffness on different aspects of cogni-
tive functioning rather than assessing general impairment 
with a widely used tool for assessing cognitive mental 
status such as MMSE. A battery of cognitive tests used in 
this study is a better measure for capturing variability in 
cognitive scores. The estimates did not change when the 
analyses were repeated using inverse probability weights 
showing that our results are less likely to be affected by 
attrition bias. Our study also has several limitations, the 
data derived from white-collar civil servants and may not 
be the representative of general populations. Given the 
longitudinal nature of the study, mortality or other com-
peting risks may have resulted in an attenuation of our 
results. Our study has limitations. Cognitive data derived 
from generally healthy, retired white-collar civil servants 
may not be broadly representative. Cognitive decline may 
be slower than among the general population, and this 
phenomenon may help to explain why we did not observe 
a clear link between aortic stiffness and change in AH4-I 
score.
In conclusion, our results indicate that high arterial stiff-
ness is associated with accelerated decline in global cogni-
tive score. Among the domains, decline in phonemic fluency 
was most clearly linked to stiffness of the aorta. We showed 
that executive function could be at risk of impairment due 
to reduced aortic compliance and loss of elasticity. Future 
studies need to determine if the interventions on reducing 
or preventing arterial stiffness can be effective in delaying 
cognitive decline.
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